Literature DB >> 7792138

Biophysical, pharmacological and developmental properties of ATP-sensitive K+ channels in cultured myotomal muscle cells from Xenopus embryos.

E Honoré1, M Lazdunski.   

Abstract

Unlike mammalian muscle cells in culture, cultured myotomal muscle cells of Xenopus embryos express ATP-sensitive K+ (KATP) channels. The KATP channels are blocked by internal ATP (half-maximal inhibition K0.5 = 16 microM) and to a lesser extent by internal ADP, are voltage independent, have an inward rectification at positive potentials and are inhibited by glibenclamide (K0.5 = 2 microM). Surprisingly, these KATP channels are not sensitive to K+ channel openers such as cromakalim. Opening of these KATP channels does not occur under normal physiological conditions. It is elicited by metabolic exhaustion of the muscle cell and it precedes the development of an irreversible rigor state. Neither intracellular acidosis nor an increase of intracellular Ca2+ are involved in KATP channel opening. Different types of K+ channels are successively expressed after plating of myotomal muscle cells: (1) sustained delayed-rectifier K+ channels; (2) KATP channels; (3) inward-rectifier K+ channels; (4) transient delayed-rectifier K+ channels. The current density associated with KATP channels far exceeds that of voltage-dependent K+ channels. Innervation controls the expression of these KATP channels. Co-culture of muscle cells with neurons from the neural tube decreases the number of active KATP channels per patch. Similarly, in situ innervated submaxillaris muscle of tadpoles at stage 50-55 has a very low density of KATP channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7792138     DOI: 10.1007/bf00373981

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  38 in total

1.  Intracellular ADP activates K+ channels that are inhibited by ATP in an insulin-secreting cell line.

Authors:  M J Dunne; O H Petersen
Journal:  FEBS Lett       Date:  1986-11-10       Impact factor: 4.124

2.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells.

Authors:  H Schmid-Antomarchi; J De Weille; M Fosset; M Lazdunski
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

3.  Studies of the unitary properties of adenosine-5'-triphosphate-regulated potassium channels of frog skeletal muscle.

Authors:  A E Spruce; N B Standen; P R Stanfield
Journal:  J Physiol       Date:  1987-01       Impact factor: 5.182

4.  Cellular ions in intact and denervated muscles of the rat.

Authors:  J P Leader; J J Bray; A D Macknight; D R Mason; D McCaig; R G Mills
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

5.  Effects of potassium channel openers on single potassium channels in mouse skeletal muscle.

Authors:  R Weik; B Neumcke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

6.  Skeletal muscle ATP-sensitive K+ channels recorded from sarcolemmal blebs of split fibers: ATP inhibition is reduced by magnesium and ADP.

Authors:  M B Vivaudou; C Arnoult; M Villaz
Journal:  J Membr Biol       Date:  1991-06       Impact factor: 1.843

7.  Nucleotide diphosphates activate the ATP-sensitive potassium channel in mouse skeletal muscle.

Authors:  B Allard; M Lazdunski
Journal:  Pflugers Arch       Date:  1992-11       Impact factor: 3.657

8.  Potassium and chloride conductances in normal and denervated rat muscles.

Authors:  H Lorković; R J Tomanek
Journal:  Am J Physiol       Date:  1977-03

9.  K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells.

Authors:  D J Beech; H Zhang; K Nakao; T B Bolton
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Potassium channels from normal and denervated mouse skeletal muscle fibers.

Authors:  A L Escobar; A F Schinder; F I Biali; L C Nicola; O D Uchitel
Journal:  Muscle Nerve       Date:  1993-06       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.